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ABSTRACT 
Background: Hypercapnia is associated with diaphragm muscle dysfunc- 
tion that is a reduction of diaphragmatic force generated for stable electric 
myographic activity. 
Objective: The purpose of this study was to test the effects of milrinone and 
olprinone on decreased iaphragmatic contractility induced by hypercapnia in
pentobarbital-anesthetized dogs. 
Methods: This experimental study was conducted at the Department of 
Anesthesiology, University of Tsukuba, Institute of Clinical Medicine, Tsukuba, 
Japan. Hypercapnia (partial pressure of carbon dioxide [CO2] in arterial blood 
80-90 mm Hg) was induced by adding 10% CO 2 to the inspired gas. When hyper- 
capnia was established, group 1 received no study drug, group 2 was infused with 
milrinone (50 1Jg/kg initial dose plus 0.5 IJg/kg • min -1 thereafter), and group 3 was 
infused with olprinone (10 iJg/kg initial dose plus 0.3 iJg/kg • min -1 thereafter). 
Diaphragmatic contractility was assessed by transdiaphragmatic pressure (Pdi). 
Results" Twenty-four, healthy, adult mongrel dogs were used in the study; 
8 dogs were assigned to each treatment group. In the presence of hypercapnia, 
in each group, Pdi (mean [SD], cm-H20 ) at low-frequency (20 Hz) and high- 
frequency (100 Hz) stimulation significantly decreased from baseline (group 1" 
20 Hz, 15.1 [2.4] vs 13.3 [2.7]; 100 Hz, 23.1 [2.7] vs 20.6 [2.5], both, P = 0.001; 
group 2:20 Hz, 15.2 [2.0] vs 13.2 [2.5]; 100 Hz, 23.0 [2.5] vs 20.5 [2.5], both, P= 
0.001; group 3:20 Hz, 15.0 [2.2] vs 13.2 [2.1]; 100 Hz, 23.0 [2.5] vs 20.5 [2.7], both, 
P = 0.001). In group 1, the change in Pdi with regard to each stimulus was not 
significant when compared with the hypercapnia-induced values. In groups 2 
and 3, during study-drug administration, Pdi increased significantly in response 
to both stimuli compared with hypercapnia-induced values (group 2:20 Hz, 13.2 
[2.5] vs 18.8 [2.2]; 100 Hz, 20.5 [2.5] vs 27.7 [2.3], both, P= 0.001; group 3:20 Hz, 
13.2 [2.1] vs 22.3 [3.5]; 100 Hz, 20.5 [2.7] vs 30.8 [2.2], both, P = 0.001). The 
increase in Pdi with both stimuli was significantly greater in group 3 than in 
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group 2 (20 Hz, 22.3 [3.5] vs 18.8 [2.2], P= 0.035; 100 Hz, 30.8 [2.2] vs 27.7 [2.3], 
P = 0.046). 
Conclusions: The results of this experimental study of the effects of milri- 
none and olprinone on hypercapnic depression of diaphragmatic contractility 
in these pentobarbital-anesthetized dogs suggest that olprinone and milrinone 
significantly improved iaphragm uscle dysfunction induced by hypercapnia. 
The effects of olprinone were significantly greater than those of milrinone. 
Further studies are needed to determine the optimal dose of the study drugs. (Curr 
Ther Res Ciin Ex~. 2007;68:175-183) Copyright © 2007 Excerpta Medica, Inc. 
Key words: muscle, diaphragm, contractility, hypercapnia, milrinone, 
olprinone. 
INTRODUCTION 
Patients with chronic airway obstruction who are hypercapnic experience limited 
performance of respiratory muscles, especially the diaphragm. 1,2 In healthy 
human subjects, hypercapnia s associated with diaphragm uscle dysfunction 
that is a reduction of diaphragmatic force generated for stable electric myo- 
graphic activity. 3Pharmacologic agents have been examined for the effects on 
diaphragmatic contractility during hypercapnia. Aminophylline and neostig- 
mine are effective for the improvement of hypercapnic depression of diaphrag- 
matic contractility, but isoproterenol does not increase reduced diaphragmat- 
ic contractility during hypercapnia. 4 Milrinone, a phosphodiesterase (PDE)-3 
inhibitor, has both inotropic and vasodilator actions that have been found to 
improve hemodynamics in patients with congestive heart failure, s Olprinone, 
an inhibitor of PDE-3, might improve cardiac performance through its inotropic 
and vasodilating effects. 6,~ It has been reported previously that contractility of 
fatigued canine diaphragm can be improved by milrinone s and olprinone. 9 How- 
ever, based on a search of MEDLINE (January 1985-September 2006) using the 
key terms muscle, diaphragm, contractility, hypercapnia, milrinone, and olprinone, 
no published data were available concerning hypercapnic depression of 
diaphragmatic contractility during the administration of PDE-3 inhibitors. The 
purpose of this study was to test the effects of milrinone and olprinone on the 
performance of the diaphragm depressed by hypercapnia in pentobarbital- 
anesthetized dogs. 
MATERIALS AND METHODS 
This experiment was conducted at the Department of Anesthesiology, Univer- 
sity of Tsukuba, Institute of Clinical Medicine, Tsukuba, Japan. The protocol was 
approved by the university's animal research committee, and the care of animals 
was in agreement with guidelines for ethical animal research. 8,9 
Healthy adult (aged >5 years) mongrel dogs weighing 10 to 15 kg (provided 
by Animal Guidance Center, Mashiko, Japan) were used in the study. Animals 
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were randomly assigned, by a computer-generated list of random numbers, to 
I of 3 treatment groups: group 1, no study drug; group 2, milrinone (50 pg]kg initial 
dose plus 0.5 pg/kg • min -1 thereafter); and group 3, olprinone (10 pg]kg initial dose 
plus 0.3 pg]kg • min -1 thereafter). The dose of study drugs (milrinone, olprinone) 
chosen in this experiment was based on preliminary studies. 8,9 
Animal preparation was similar to that described previously, s 9 Briefly, anes- 
thesia was maintained with IV pentobarbital 2 mg/kg • h -1. The dose used in this 
study had been found to have no effect on diaphragmatic contractility in dogs. 1° 
No muscle relaxant was used. Each dog underwent tracheal intubation, and 
ventilation was mechanically controlled using a mixture of oxygen (02) 1 L/min 
and air 2 L/min (fraction of inspired 0 2, 0.4) to maintain arterial blood pH 7.35 
to 7.45, partial pressure of carbon dioxide (CO2) in arterial blood (Pco2) 35 to 
40 mm Hg, and partial pressure of 02 in arterial blood (Po2) > 100 mm Hg. The right 
femoral artery was cannulated for monitoring arterial blood pressure. The right 
femoral vein was cannulated for administering maintenance fluids ~inger's lac- 
tated solution, 10 mL/kg • h -1) and pentobarbital. The left femoral vein was cannu- 
lated for administration of the study drug. Transdiaphragmatic pressure (Pdi) was 
measured by using 2 thin-walled latex balloons---one positioned in the stomach 
and the other positioned in the middle third of the esophagus. Balloons were con- 
nected to a differential pressure transducer (TP 604T, Nihon Koden, Tokyo, Japan) 
and an amplifier (Model 1257, Nihondenki San-el, Tokyo, Japan). Phrenic nerves 
were bilaterally exposed at the neck, and stimulating electrodes were placed 
around them. Supramaximal e ectrical stimuli (10-15 V) of 0.1 ms duration were 
applied for 2 seconds at low-frequency (20-Hz) and high-frequency (100-Hz) stimu- 
lation with an electrical stimulator (SEN-3301, Nihon Koden). Diaphragmatic con- 
tractility was assessed by measuring the maximal Pdi generated by test stimuli 
after airway occlusion at functional residual capacity. Electrical activity of the 
diaphragm was recorded by using 2 pairs of fishhook electrodes, and its signal was 
rectified and integrated using an integrator (Type 1322, Nihondenki San-el) with a 
time constant of 0.1 second. This was regarded as the integrated electrical activi- 
ty of the crural (Edi-cru) and costal ~di-cost) parts of the diaphragm. 
Dogs were allowed to stabilize for 30 minutes before study initiation following 
animal preparation. Baseline measurements of hemodynamic variables (heart 
rate [HR], mean arterial pressure [MAP]), arterial blood gas tensions (pH, Pco2, 
Po2), Pdi, Edi-cru, and Edi-cost were recorded in each group. Hypercapnia (Pco 2 
80-90 mm Hg) was produced by adding 10% CO 2 to the inspired gas. When 
hypercapnia was established at 2 hours after the onset of CO 2 administration, 
group 1 received no study drug, group 2 was infused with milrinone (50 pg/kg 
initial dose plus 0.5 pg]kg • min -1 thereafter), and group 3 was infused with olpri- 
none (10 pg]kg initial dose plus 0.3 1Jg/kg • min -1 thereafter). Study drug was 
continuously administered intravenously for 1 hour with an infusion pump. 
After administering the study drug, HR, MAP, Pdi, Edi-cru, and Edi-cost were 
measured. Percentage changes from baseline in Edi-cru (%Edi-cru) and Edi-cost 
(%Edi-cost) were calculated. 9 
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Statistical Analysis 
Assuming an ¢z of 0.05 and 13 of 0.2, a sample size of 8 dogs in each group 
would be powered to detect a difference in Pdi at 20-Hz and 100-Hz stimulation 
among baseline, hypercapnia, and treatment periods. Reported values are 
mean (SD). Statistical analyses were performed by using analysis of variance for 
repeated measurements, followed by the Bonferroni-Dunn test for multiple 
comparisons, paired t test, and Student test, where appropriate. P < 0.05 was 
considered statistically significant. Analyses were performed using the 
Statistical Package for Social Science version 8.0 (SPSS Inc., Chicago, Illinois). 
RESULTS 
Twenty-four dogs (15 males and 9 females; mean [SD] weight, 12.3 [1.6] kg) were 
included in the study; 8 dogs were assigned to each treatment group. No signif- 
icant differences in baseline hemodynamic variables (FIR, MAP), arterial blood 
gas tensions (pH, Pco 2, Po2), Pdi, Edi-cru, or Edi-cost were observed between 
the 3 groups. 
Table I shows the measurements recorded for hemodynamic variables and 
arterial blood gas tension. When hypercapnia was established, in each group 
HR (mean [SD], bpm) and MAP (mean [SD], mm Hg) significantly increased from 
baseline (group 1" HR, 140 [10] vs 150 [11]; MAP, 122 [8] vs 133 [7], both, P = 
0.001; group 2: HR, 140 [9] vs 151 [10]; MAP, 121 [10] vs 133 [8], both, P= 0.001; 
group 3: HR, 138 [9] vs 149 [10]; MAP, 121 [9] vs 132 [8], both, P= 0.001). With 
an infusion of milrinone (group 2) and olprinone (group 3), HR significantly 
increased and MAP significantly decreased from those values obtained during 
hypercapnia (group 2: HR, 151 [10] vs 161 [8]; MAP, 133 [8] vs 120 [9], both, P= 
0.001; group 3: HR, 149 [10] vs 159 [9]; MAP, 132 [8] vs 121 [8], both, P = 0.001). 
The administration of CO, was associated with a significant decrease in pH 
(mean [SD]) and a significant increase in Pco 2 (mean [SD], rain Hg) in each group 
(group 1" pH, 7.39 [0.01] vs 7.13 [0.01]; Pco 2, 36.8 [1.5] vs 86.0 [2.5], both, P= 0.001; 
group 2: pH, 7.40 [0.01] vs 7.13 [0.02]; Pco 2, 37.0 [1.5] vs 85.8 [2.8], both, P= 0.001; 
group 3: pH, 7.42 [0.01] vs 7.13 [0.02]; Pco 2, 37.1 [1.5] vs 85.5 [3.7], both, P= 0.001). 
No significant difference in Po 2 was found throughout the experiment. 
Table II shows the changes in Pdi, Edi-cru, and Edi-cost from baseline to 
treatment. In the presence of hypercapnia, in each group Pdi (mean [SD], cm-H20 ) 
at both stimuli levels decreased significantly from baseline (group 1" 20 Hz, 
15.1 [2.4] vs 13.3 [2.7]; 100 Hz, 23.1 [2.7] vs 20.6 [2.5], both, P = 0.001; group 2: 
20 Hz, 15.2 [2.0] vs 13.2 [2.5]; 100 Hz, 23.0 [2.5] vs 20.5 [2.5], both, P = 0.001; 
group 3:20 Hz, 15.0 [2.2] vs 13.2 [2.1]; 100 Hz, 23.0 [2.5] vs 20.5 [2.7], both, P= 
0.001). In groups 2 and 3, during the administration of the study drug, Pdi at 
both stimuli levels significantly increased from hypercapnia-induced values 
(group 2:20 Hz, 13.2 [2.5] vs 18.8 [2.2]; 100 Hz, 20.5 [2.5] vs 27.7 [2.3], both, P= 
0.001; group 3:20 Hz, 13.2 [2.1] vs 22.3 [3.5]; 100 Hz, 20.5 [2.7] vs 30.8 [2.2], both, 
P = 0.001). The increase in Pdi at both stimuli levels was significantly greater in 
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Table I. Changes in hemodynamics and arterial blood gas tensions in pentobarbital- 
anesthetized dogs with induced hypercapnia treated with milrinone or olpri- 
none. All values are reported as mean (SD). 
Variables Group Baseline Hypercapnia Treatment 
Hemodynamics 
HR, bpm 
MAP, m m Hg 
Arterial blood gas 
tensions 
pH 
Pco2, mm Hg 
Po2, mm Hg 
1 140 (10) 150 (11)* 149 (10)* 
2 140 (9) 151 (10)* 161 (8) *t~ 
3 138 (9) 149 (10)* 159 (9) **~ 
1 122 (8) 133 (7)* 132 (8)* 
2 121 (10) 133 (8)* 120 (9)t~ 
3 121 (9) 132 (8)* 121 (8)t~ 
1 7.39 (0.01) 7.13 (0.01)* 7.14 (0.01)* 
2 7.40 (0.01) 7.1 3 (0.02)* 7.14 (0.02)* 
3 7.42 (0.01) 7.13 (0.02)* 7.15 (0.02)* 
1 36.8 (1.5) 86.0 (2.5)* 86.0 (2.3)* 
2 37.0 (1.5) 85.8 (2.8)* 85.5 (2.2)* 
3 37.1 (1.5) 85.5 (3.7)* 85.1 (2.2)* 
1 150.0 (1.8) 151.0 (3.3) 150.3 (2.6) 
2 150.0 (2.0) 150.0 (1.8) 1.50.2 (2.5) 
3 150.3 (2.1) 149.1 (2.1) 150.0 (2.0) 
Group 1 = no study drug; group 2 = milrinone; group 3 = olprinone; HR = heart rate; MAP = mean arte- 
rial pressure; Pco  2 = partial pressure of carbon dioxide in arterial blood; Po 2 = partial pressure of oxy- 
gen in arterial blood. 
*P = 0.001 versus baseline value. 
tp = 0.001 versus hypercapnia value. 
SP < 0.05 versus group 1 value. 
group 3 when compared with group 2 (20 Hz, 22.3 [3.5] vs 18.8 [2.2], respectively, 
P= 0.035; 100 Hz, 30.8 [2.2] vs 27.7 [2.3], respectively, P = 0.046). In group 1, Pdi 
level with regard to each stimulus did not change from hypercapnia-induced 
values. No significant changes in %Edi-cru or %Edi-cost were observed through- 
out the study in any group (Table If). 
DISCUSSION 
Signs of CO 2 retention in humans are tachycardia nd hypertension. 11 When 
hypercapnia was established in the present study, HR and MAP significantly 
increased from baseline (both, P < 0.05). It has been found that hypercapnia 
impairs diaphragmatic contractility in vivo 12 and in vitro. 13 In the present study, 
we found that Pdi at 20-Hz and 100-Hz stimulation significantly decreased by 
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Table II. Changes in transdiaphragmatic pressure (Pdi) and the integrated electrical 
activity of the diaphragm in pentobarbital-anesthetized dogs with induced 
hypercapnia treated with milrinone or olprinone. All values are reported as 
mean (SD). 
Variable Group Baseline Hypercapnia Treatment 
Pdi, cm-H20 
20-Hz stimulation 
100-Hz stimulation 
Edi-cru, % 
20-Hz stimulation 
100-Hz stimulation 
Edi-cost, % 
20-Hz stimulation 
100-Hz stimulation 
1 15.1 (2.4) 13.3 (2.7)* 13.4 (2.8)* 
2 15.2 (2.0) 13.2 (2.5)* 18.8 (2.2)*t$ 
3 15.0 (2.2) 1 3.2 (2.1)* 22.3 (3.5)***§ 
1 23.1 (2.7) 20.6 (2.5)* 21.3 (2.6)* 
2 23.0 (2.5) 20.5 (2.5)* 27.7 (2.3) *t$ 
3 23.0 (2.5) 20.5 (2.7)* 30.8 (2.2)*t$§ 
1 100 98.8 (6.9) 99.0 (2.8) 
2 100 99.2 (2.5) 99.2 (2.5) 
3 1 O0 100.0 (4.2) 99.0 (2.8) 
1 100 99.5 (1.4) 99.7 (0.7) 
2 100 99.2 (2.0) 99.2 (2.0) 
3 100 99.7 (0.7) 99.7 (0.7) 
1 100 99.0 (2.8) 99.0 (2.8) 
2 100 99.2 (2.5) 99.2 (2.5) 
3 100 99.0 (2.8) 99.0 (2.8) 
1 1 O0 99.5 (1.4) 100.5 (1.4) 
2 100 99.2 (2.0) 99.2 (2.0) 
3 100 99.6 (1.0) 99.6 (1.0) 
Group 1 = no study drug; group 2 = milrinone; group 3 = olprinone; Edi-cru = integrated electrical 
activity of the crural part of the diaphragm; Edi-cost = integrated electrical activity of the costal part of 
the diaphragm. 
*P = 0.001 versus baseline value. 
tp = 0.001 versus hypercapnia value. 
SP < 0.05 versus group 1 value. 
§P < 0.05 versus group 2 value. 
-15% from baseline (all, P = 0.001) in the presence of hypercapnia. This was in 
accordance with a previous report suggesting that development of hypercapnia 
0~co2, 87 mm Hg) was associated with a 10% reduction in Pdi at low and high fre- 
quencies of stimulation. 4 The mechanism by which hypercapnia reduces diaphrag- 
matic contractility is not known, but there is a possibility that an alteration of mus- 
cle pH might be associated with a decrease in the affinity of troponin for calcium, 
an increase in the binding of calcium by the sarcoplasmic reticulum, or a reduction 
of the rate of glycolysis and thus adenosine tr iphosphate resynthesis. 14-16 
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In this experiment, we found that Pdi at 20-Hz and 100-Hz stimulation signifi- 
cantly increased from hypercapnia-induced values (all, P = 0.001) with an infu- 
sion of milrinone or olprinone. The exact mechanism by which milrinone or 
olprinone improves diaphragmatic contractility during hypercapnia remains 
unclear. In preliminary studies we have conducted, 89 these PDE-3 inhibitors 
were thought o have a direct positive effect on diaphragmatic contractility. 
Also, our results suggest hat Pdi at both levels of stimuli during olprinone 
administration was significantly more than those during milrinone administra- 
tion (both, P < 0.05). This suggests that olprinone was more effective than mil- 
rinone for the improvement of hypercapnia-induced contractility of the 
diaphragm in these dogs. The reason for this difference is unknown, but it might 
be associated with the difference in a positive inotropic action of these PDE-3 
inhibitors on hypercapnic depression of the diaphragm. 
Based on a MEDLINE search, this is the first report to examine the effects of 
milrinone and olprinone on hypercapnic depression of diaphragmatic contrac- 
tility. The following limitations of the study should be considered. First, the 
dose of study drugs (milrinone, olprinone) chosen in this experiment would not 
be appropriate for the improvement of hypercapnic depression of diaphragmatic 
contractility. The recommended dosage for the improvement of the myocardial 
performance is a 50 pg/kg initial dose plus 0.5 pg/kg • min -1 thereafter for milri- 
none sand a 10 pg/kg initial dose plus 0.3 pg/kg • min -1 thereafter for olprinone. 17 
Previously, we examined the diaphragm muscle function during fatigue by 
administering milrinone (0.5 pg/kg, min -1) or olprinone (0.3 pg/kg, min -1) in 
dogs, and found that milrinone and olprinone both significantly increased ia- 
phragmatic ontractility from baseline. 8,9 The same doses of these drugs were 
chosen for the present study. However, further study is required to determine 
the optimal dose of study drugs for the improvement of diaphragm uscle dys- 
function induced by hypercapnia. Second, the mechanisms by which milrinone 
and olprinone effectively improve hypercapnic depression of diaphragmatic 
contractility was not studied. Regardless of unknown mechanisms, results of 
the present study have important implications for the diaphragm muscle dys- 
function associated with hypercapnia. Third, the control group did not receive 
saline. However, we have previously found no effects of placebo (saline) on 
diaphragm uscle function in pentobarbital-anesthetized dogs. 18 Further stud- 
ies should consider these limitations. 
CONCLUSIONS 
The results of this experimental study of effects of milrinone and olprinone 
on hypercapnic depression of diaphragmatic contractility in pentobarbital- 
anesthetized dogs suggests that olprinone and milrinone effectively improved 
diaphragm muscle dysfunction induced by hypercapnia. Olprinone was signifi- 
cantly more effective than milrinone. Further studies are needed to determine 
the optimal dose of the study drugs and are required to elucidate the mecha- 
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nism by which s tudy drugs effectively improve hypercapnic  depress ion of 
d iaphragmat ic  contractil ity. 
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